L04AA04 • anti-lymphocyte immunoglobulin (rabbit) • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Rabbit anti-lymphocyte immunoglobulin is used for the prevention and treatment of acute rejection in organ transplantation. It works by suppressing the body's immune response, reducing T-lymphocyte activity.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include fever, chills, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or opportunistic infections may occur.
Rabbit anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to animal-derived proteins or active severe infections.
Substance: anti-lymphocyte immunoglobulin (rabbit)
Date of last drug list: 01-06-2025
Commercial code: W61725001
Concentration: 20mg / ml
Pharmaceutical form: perfusive solution concentrate
Packing volume: 5 ml
Product type: original
Price: 1548.08 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: NEOVII BIOTECH GMBH - GERMANIA
Holder: NEOVII BIOTECH GMBH - GERMANIA
Number: 7711/2015/01
Shelf life: 2 years
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
Price
Copayment
Patient
1548.08 RON
1548.08 RON
0.00 RON